Inzitari D, Cadelo M, Marranci M L, Pracucci G, Pantoni L
Department of Neurological and Psychiatric Sciences, University of Florence, Italy.
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):177-81. doi: 10.1136/jnnp.62.2.177.
The prognostic significance of leukoaraiosis is still not completely elucidated. The objective was to examine survival and causes of death among elderly neurological patients with leukoaraiosis.
From 1 January 1994, vital status and causes of death were drawn from municipality lists and death certificates of 216 patients (mean age (SD) 70.6 (8.3) years) admitted to a geriatric unit who underwent cranial CT between 1 January 1984 and 31 December 1986 (mean observation period (SD) 8.4 (0.8) years). These patients had been enrolled for a study of clinical predictors of leukoaraiosis. Based on the presence of leukoaraiosis on CT, this group had been divided into two subgroups of patients, with and without leukoaraiosis. The difference in survival and causes of death between these groups formed the objective of the study.
Survival time was shorter among the 90 patients with leukoaraiosis than among the 126 patients without (median survival time 4.07 v 7.78 years, log rank test P < 0.001). After controlling for age and other major death predictors, the risk of death remained significantly increased (relative risk (RR) = 1.64, 95% confidence interval (95% CI) 1.15-2.34) among patients with leukoaraiosis. Moreover, patients with leukoaraiosis had an almost threefold higher risk of dying from vascular causes than patients without (RR = 2.81, 95% CI 1.74-4.53).
Leukoaraiosis is a predictor of vascular deaths in elderly neurological patients. Careful diagnostic evaluation and attention to preventive measures are required in patients with leukoaraiosis.
脑白质疏松症的预后意义仍未完全阐明。本研究旨在探讨患有脑白质疏松症的老年神经科患者的生存率及死亡原因。
从1994年1月1日起,通过市政名单和死亡证明获取了216例患者(平均年龄(标准差)70.6(8.3)岁)的生命状态和死亡原因,这些患者于1984年1月1日至1986年12月31日期间入住老年病房,并接受了头颅CT检查(平均观察期(标准差)8.4(0.8)年)。这些患者曾参与一项关于脑白质疏松症临床预测因素的研究。根据CT上脑白质疏松症的有无,该组患者被分为有脑白质疏松症和无脑白质疏松症的两个亚组。两组之间生存率和死亡原因的差异构成了本研究的目的。
90例患有脑白质疏松症的患者的生存时间短于126例无该病的患者(中位生存时间4.07对7.78年,对数秩检验P<0.001)。在控制年龄和其他主要死亡预测因素后,患有脑白质疏松症的患者死亡风险仍显著增加(相对风险(RR)=1.64,95%置信区间(95%CI)1.15 - 2.34)。此外,患有脑白质疏松症的患者死于血管性原因的风险几乎是无该病患者的三倍(RR = 2.81,95%CI 1.74 - 4.53)。
脑白质疏松症是老年神经科患者血管性死亡的一个预测因素。对于患有脑白质疏松症的患者,需要进行仔细的诊断评估并关注预防措施。